--- title: (2) description: (2) --- [![HUB Organoids](https://blog.huborganoids.nl/hubfs/raw_assets/public/HUBOrganoids_May2021/images/logo-huborganoids-white.svg "HUB Organoids")](https://huborganoids.nl/) ![merk-m-logo-blue](https://blog.huborganoids.nl/hs-fs/hubfs/merk-m-logo-blue.png?width=728&height=225&name=merk-m-logo-blue.png) - [services](https://huborganoids.nl/services) - [services overview](https://www.huborganoids.nl/services-overview/) - [drug screening](https://www.huborganoids.nl/services/hub-drug-screening/) - [model and assay development](https://www.huborganoids.nl/services/) - [clinical trials in a dish](https://www.huborganoids.nl/hub-organoid-clinical-trial-in-a-dish/) - [Technology](https://huborganoids.nl/hub-technology) - [Company](https://huborganoids.nl/about) - [about us](https://huborganoids.nl/about) - [Careers](https://huborganoids.nl/careers) - [events](https://www.huborganoids.nl/meet-us/) - [latest news](https://www.huborganoids.nl/news-insights-2/) - [Resources](https://huborganoids.nl/resources/) - [Blog](https://blog.huborganoids.nl) - [license program](https://www.huborganoids.nl/licenses/) - [Contact](https://resources.huborganoids.nl/contact-hub) [discover organoid services](https://www.huborganoids.nl/services-overview/) - [services](https://huborganoids.nl/services) - [services overview](https://www.huborganoids.nl/services-overview/) - [drug screening](https://www.huborganoids.nl/services/hub-drug-screening/) - [model and assay development](https://www.huborganoids.nl/services/) - [clinical trials in a dish](https://www.huborganoids.nl/hub-organoid-clinical-trial-in-a-dish/) - [Technology](https://huborganoids.nl/hub-technology) - [Company](https://huborganoids.nl/about) - [about us](https://huborganoids.nl/about) - [Careers](https://huborganoids.nl/careers) - [events](https://www.huborganoids.nl/meet-us/) - [latest news](https://www.huborganoids.nl/news-insights-2/) - [Resources](https://huborganoids.nl/resources/) - [Blog](https://blog.huborganoids.nl) - [license program](https://www.huborganoids.nl/licenses/) - [Contact](https://resources.huborganoids.nl/contact-hub) # HUB's blog ![PDO Screen – Patient-derived Organoids meet Cancer Modeling](https://blog.huborganoids.nl/hubfs/organoid-stained-dapi.png) ### [PDO Screen – Patient-derived Organoids meet Cancer Modeling](https://blog.huborganoids.nl/pdo-screen-patient-derived-organoids-meet-cancer-modeling) Published by HUB Organoids on Mar 21, 2023 Discover how patient-derived organoids can revolutionize oncology research by enabling accurate modeling of tumor biology and predicting patient response to treatment. [read more](https://blog.huborganoids.nl/pdo-screen-patient-derived-organoids-meet-cancer-modeling) ![The FDA Modernization Act 2.0: A patient-centric paradigm shift in drug development](https://blog.huborganoids.nl/hubfs/fda-modernization-act.png) ### [The FDA Modernization Act 2.0: A patient-centric paradigm shift in drug development](https://blog.huborganoids.nl/patient-centric-drug-development-with-organoids) Published by HUB Organoids on Jan 16, 2023 Explore what the new legislative bill means for the future of ... [read more](https://blog.huborganoids.nl/patient-centric-drug-development-with-organoids) ![Challenges in preclinical modeling of cancer immunity](https://blog.huborganoids.nl/hubfs/cancer-immunity.jpg) ### [Challenges in preclinical modeling of cancer immunity](https://blog.huborganoids.nl/challenges-in-preclinical-modeling-of-cancer-immunity) Published by HUB Organoids on Nov 1, 2022 Learn how to select the right model for your immunotherapy ... [read more](https://blog.huborganoids.nl/challenges-in-preclinical-modeling-of-cancer-immunity) ![Do you need a license to work with HUB Organoid® Technology?](https://blog.huborganoids.nl/hubfs/Copy%20of%20HUB%20News%20(4).png) ### [Do you need a license to work with HUB Organoid® Technology?](https://blog.huborganoids.nl/do-you-need-a-license) Published by Dnyanada Sahasrabudhe on Jul 7, 2022 Explore HUB’s license offerings and how they apply to your organoid ... [read more](https://blog.huborganoids.nl/do-you-need-a-license) ![Forecasting a champion: How HUB Organoids® can speed up the drug development timeline to about five years](https://blog.huborganoids.nl/hubfs/pre-clinical-discovery-testing-thumb.jpg) ### [Forecasting a champion: How HUB Organoids® can speed up the drug development timeline to about five years](https://blog.huborganoids.nl/how-hub-organoids-can-speed-up-the-drug-development-timeline) Published by Dnyanada Sahasrabudhe on May 17, 2022 Learn why you should invest in patient-derived HUB Organoids® for ... [read more](https://blog.huborganoids.nl/how-hub-organoids-can-speed-up-the-drug-development-timeline) ![Ask the experts - organoids as model systems](https://blog.huborganoids.nl/hubfs/Copy%20of%20HUB%20News%20(22).png) ### [Ask the experts - organoids as model systems](https://blog.huborganoids.nl/ask-the-experts-organoids-as-model-systems) Published by Federica Parisi, PhD on Oct 14, 2021 In this last episode of our "Ask the experts" series we explore the ... [read more](https://blog.huborganoids.nl/ask-the-experts-organoids-as-model-systems) ![Ask the experts - organoids in drug development](https://blog.huborganoids.nl/hubfs/Copy%20of%20HUB%20News%20(1)-1.png) ### [Ask the experts - organoids in drug development](https://blog.huborganoids.nl/ask-the-experts-organoids-in-drug-development) Published by Federica Parisi, PhD on Sept 30, 2021 After discussing HUB Organoids™ applications to viral and oncology ... [read more](https://blog.huborganoids.nl/ask-the-experts-organoids-in-drug-development) ![Ask the experts - organoids for oncology studies](https://blog.huborganoids.nl/hubfs/Copy%20of%20HUB%20News%20(21).png) ### [Ask the experts - organoids for oncology studies](https://blog.huborganoids.nl/ask-the-experts-organoids-for-oncology) Published by Federica Parisi, PhD on Sept 9, 2021 In the first post from our "Ask the experts" series we have answered ... [read more](https://blog.huborganoids.nl/ask-the-experts-organoids-for-oncology) ![Ask the experts - organoids for viral infection studies](https://blog.huborganoids.nl/hubfs/Copy%20of%20HUB%20News%20(17)-1.png) ### [Ask the experts - organoids for viral infection studies](https://blog.huborganoids.nl/ask-the-experts-organoids-for-viral-infection) Published by Federica Parisi, PhD on Aug 25, 2021 HUB and STEMCELL Technologies experts gathered virtually for a ... [read more](https://blog.huborganoids.nl/ask-the-experts-organoids-for-viral-infection) [View Recent Posts](https://blog.huborganoids.nl/page/1) ![HUB Organoids](https://blog.huborganoids.nl/hubfs/raw_assets/public/HUBOrganoids_May2021/images/logo-huborganoids-white.svg "HUB Organoids") [Privacy Policy](https://huborganoids.nl/privacy-policy) HUB Organoids is now part of the Life Science Business of Merck KGaA, Darmstadt, Germany ***FOR RESEARCH USE ONLY.**  Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.*